Futures
Hundreds of contracts settled in USDT or BTC
TradFi
Gold
Trade global traditional assets with USDT in one place
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Participate in events to win generous rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and enjoy airdrop rewards!
Futures Points
Earn futures points and claim airdrop rewards
Investment
Simple Earn
Earn interests with idle tokens
Auto-Invest
Auto-invest on a regular basis
Dual Investment
Buy low and sell high to take profits from price fluctuations
Soft Staking
Earn rewards with flexible staking
Crypto Loan
0 Fees
Pledge one crypto to borrow another
Lending Center
One-stop lending hub
VIP Wealth Hub
Customized wealth management empowers your assets growth
Private Wealth Management
Customized asset management to grow your digital assets
Quant Fund
Top asset management team helps you profit without hassle
Staking
Stake cryptos to earn in PoS products
Smart Leverage
New
No forced liquidation before maturity, worry-free leveraged gains
GUSD Minting
Use USDT/USDC to mint GUSD for treasury-level yields
Strategic Portfolio Refinement: Azenta Divests B Medical Systems Unit To THELEMA For $63 Million
Azenta Inc. (AZTA) has finalized a definitive agreement through its subsidiary Azenta Germany GmbH to offload its B Medical Systems division—a leading player in manufacturing and distributing refrigerated medical storage solutions—to THELEMA S.À R.L. under a $63 million transaction. This divestiture represents a significant step in the company’s broader strategic repositioning effort.
Transaction Timeline And Financial Impact
The sale is projected to be completed by March 31, 2026. Upon closing, Azenta intends to redirect the capital proceeds toward reinforcing operational capabilities and fostering sustainable profitability. The transaction underscores management’s commitment to optimizing the company’s asset base for long-term shareholder value.
Strategic Rationale Behind The Divestiture
By shedding the B Medical Systems unit, Azenta is consolidating its focus on business segments that deliver the highest strategic returns. The move reflects a deliberate effort to eliminate non-core assets and channel resources toward segments with superior growth and margin potential. This portfolio optimization aligns with evolving market dynamics and investor expectations for operational efficiency.
Market Response
Following the announcement, AZTA shares demonstrated positive momentum on the Nasdaq, closing at $34.75, reflecting a 0.70 percent gain. The market’s reception suggests investor confidence in management’s strategic direction and capital allocation discipline.